Created with Sketch.
Pathfinders in Biopharma
19 minutes | 2 months ago
5AM Ventures: Fueling the Next Generation of Innovators
In this episode of Pathfinders, Brian Abrahams, Managing Director and Co-Head of Biotechnology Equity Research at RBC Capital Markets speaks with Andy Schwab, Co-Founder and Managing Partner at 5AM Ventures.Key PointsPrescription Digital Therapeutics will be vital to future treatmentUnlocking microbiome could lead to better disease management
23 minutes | 2 months ago
Vida Ventures: Powering Breakthroughs in Biopharma
Luca Issi, Senior Biotechnology Research Analyst at RBC Capital Markets, discusses the art of building biopharma breakthroughs with Arjun Goyal, Co-Founder and Managing Director of Vida Ventures.Key PointsMaturation of the industry is increasing innovation and capital inflowsStrong science, management and investors can keep the IPO window open
20 minutes | 3 months ago
Biotech IPOs: Navigating the New Landscape
Even in a boom, many biotech executives may be unprepared for the risks involved in undertaking an IPO. Noël Brown and Tim Papp, Managing Directors focused on biotechnology in our Global Healthcare Investment Banking and Jason Levitz, Head of Healthcare Equity Capital Markets at RBC Capital Markets discuss the right steps to take, and the pitfalls to avoid, in today’s markets.
23 minutes | 3 months ago
Biotech IPOs: New Steps to Success on the Road to Going Public
In our launch edition of Pathfinders, we look at the best practices to follow on the road to IPO and the new predictive factors for success in today’s buoyant biopharma markets.
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2020